Sign in
8-K

Current Report

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-20-065330

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading tm2020791d1_8k.htm…